Imvax has secured $29m in a financing round from current investors, aimed at advancing the Phase IIb trial of its autologous ...
DelveInsight’s Advanced Cervical Cancer pipeline report depicts a robust space with 70+ active players working to develop 75+ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback